Publications by authors named "Matthew Brouillette"

Claim this Profile
I
Inpatient burden of COVID-19 in Japan: A retrospective cohort study.
Kathleen M Andersen, Matthew A Brouillette, Kanae Togo, Kosuke Tanabe, Benjamin T Carter

J Infect Chemother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2023-2024 COVID-19 vaccine uptake among immunocompromised individuals in two US states.
Leah J McGrath, Farid L Khan, Santiago M C Lopez, Matthew A Brouillette, Kathleen M Andersen

Vaccine· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of prurigo nodularis in the United States.
Shawn G Kwatra, Jorge Puelles, Oth Tran, Matthew Brouillette, Timothy Lillehaugen

JAAD Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Patterns in Patients with Locally Advanced or Metastatic Non-Small-Cell Lung Cancer Treated with Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors: Analysis of US Insurance Claims Databases.
Ross A Soo, Takashi Seto, Jhanelle E Gray, Ellen Thiel, Aliki Taylor, Matthew Brouillette

Drugs Real World Outcomes· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The direct and indirect costs of adult atopic dermatitis.
Janna Manjelievskaia, Natalie Boytsov, Matthew A Brouillette, Uchenna Onyekwere, Evangeline Pierce

J Manag Care Spec Pharm· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation and associated costs in biologic treatment of psoriasis based on real-world data.
Jerry Bagel, Brad Glick, Jashin J Wu, Ishveen Chopra, Xue Song, Matthew Brouillette

J Med Econ· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Treatment Initiation and Healthcare Costs in Alzheimer's Disease.
Christopher M Black, Richard B Lipton, Ellen Thiel, Matthew Brouillette, Rezaul Khandker

J Alzheimers Dis· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.
Xue Song, Antoine C El Khoury, Matthew Brouillette, David Smith, Kruti Joshi

J Med Econ· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment patterns and costs among biologic-naive patients initiating apremilast or biologics for psoriatic arthritis.
Steven R Feldman, Corey L Pelletier, Kathleen L Wilson, Rina K Mehta, Matthew A Brouillette

J Comp Eff Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world US healthcare costs of psoriasis for biologic-naive patients initiating apremilast or biologics.
Steven R Feldman, Corey L Pelletier, Kathleen L Wilson, Rina K Mehta, Matthew A Brouillette

J Comp Eff Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare costs among adults with type 2 diabetes initiating saxagliptin or linagliptin: a US-based claims analysis.
Amanda M Kong, Sepehr Farahbakhshian, Trudy Pendergraft, Matthew A Brouillette, Biswarup Mukherjee

Curr Med Res Opin· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting.
Amanda M Farr, Stephen S Johnston, Corey Ritchings, Matthew Brouillette, Lisa Rosenblatt

J Med Econ· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No difference in persistence to treatment with atazanavir or darunavir in HIV patients in a real-world setting.
Amanda M Farr, Stephen S Johnston, Corey Ritchings, Matthew Brouillette, Lisa Rosenblatt

J Int AIDS Soc· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Healthcare Costs Among Adults with Type 2 Diabetes Initiating DPP-4 Inhibitors.
Amanda M Farr, John J Sheehan, Matthew Brouillette, David M Smith, Stephen S Johnston

Adv Ther· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis